John‐Michael Williford
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
-
- Advanced biosensing and bioanalysis techniques 5
- RNA Interference and Gene Delivery 5
- Oncology 4
- Cancer Immunotherapy and Biomarkers 3
- CAR-T cell therapy research 2
- Co-authors
- Hai‐Quan Mao (7 shared papers)José Luís Santos (4 shared papers)John W. Hickey (1 shared paper)Yong Ren (5 shared papers)Jun Ishihara (4 shared papers)Jeffrey A. Hubbell (4 shared papers)Aslan Mansurov (4 shared papers)Melody A. Swartz (4 shared papers)
- Journals
- Nature Biomedical Engineering (2 papers)Small (2 papers)Science Translational Medicine (1 paper)Journal of Materials Chemistry B (1 paper)Biomaterials Science (1 paper)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
John‐Michael Williford
11 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 96
- Biomaterials 312
- Immunology 342
- Pharmaceutical Science 81
- Oncology 302
- Surfaces, Coatings and Films 60
Countries citing papers authored by John‐Michael Williford
This map shows the geographic impact of John‐Michael Williford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John‐Michael Williford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John‐Michael Williford more than expected).
Fields of papers citing papers by John‐Michael Williford
This network shows the impact of papers produced by John‐Michael Williford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John‐Michael Williford. The network helps show where John‐Michael Williford may publish in the future.
Co-authors
The 25 scholars most cited alongside John‐Michael Williford, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 294 | |
| 2 | 2020 | 178 | |
| 3 | 2019 | 147 | |
| 4 | 2014 | 135 | |
| 5 | 2012 | 107 | |
| 6 | 2019 | 99 | |
| 7 | 2015 | 97 | |
| 8 | 2016 | 71 | |
| 9 | 2022 | 63 | |
| 10 | 2014 | 12 | |
| 11 | 2016 | 1 |
About John‐Michael Williford
John‐Michael Williford is a scholar working on Molecular Biology, Oncology, Immunology, Radiology, Nuclear Medicine and Imaging and Biomaterials, having authored 11 papers that have together received 1.2k indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (5 papers), RNA Interference and Gene Delivery (5 papers), Immunotherapy and Immune Responses (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), CAR-T cell therapy research (2 papers), Nanoparticle-Based Drug Delivery (2 papers) and Nanopore and Nanochannel Transport Studies (2 papers). The work is most often cited by research in Biomaterials (312 citations), Immunology (342 citations), Pharmaceutical Science (81 citations), Oncology (302 citations) and Surfaces, Coatings and Films (60 citations). John‐Michael Williford has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Hai‐Quan Mao, José Luís Santos, John W. Hickey, Yong Ren, Jun Ishihara, Jeffrey A. Hubbell, Aslan Mansurov, Melody A. Swartz, Peyman Hosseinchi and Ako Ishihara. Their work appears in journals such as Nature Biomedical Engineering, Small, Science Translational Medicine, Journal of Materials Chemistry B and Biomaterials Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.